Xcout Intel
2cureX competitors & alternatives
The 12 closest competitors and alternatives to 2cureX among health care companies — ranked by similarity to what 2cureX actually does, not by market-cap band.
Subscribe to see 2cureX’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About 2cureX
2cureX develops products for individualized therapy selection in oncology, utilizing 3D cell culture technologies to create patient-derived tumor models for drug sensitivity testing. Its IndiTreat technology enables healthcare professionals to evaluate drug responses using 3D microtumors, helping doctors select optimal cancer treatments for individual patients.
2cureX at a glance
2cureX is a health care company headquartered in Sweden. Xcout tracks 8 named people at 2cureX, including Kenneth Graabek Johansen (CFO).
2cureX leadership
- Kenneth Graabek JohansenCFO
- Jacob ThastrupCTO
- Tonni Bülow-NielsenChairman
- Ole ThastrupCEO, Founder and Board member
- Grith HagelVP Innovation, Co-Founder and Board member
- Manuel FernándezQA/RA Director
2 more named people on record for 2cureX, with roles, board committees and tenure — see the full roster →
Top 12 2cureX competitors
Ranked by semantic similarity — how close each company is to 2cureX by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Pear Bio develops personalized cancer testing and drug discovery services for patients with hard-to-treat cancers. The company utilizes patient tumor biopsies to create 3D immune-microtumors in order to predict individual treatment responses and identify novel therapeutic targets.
Biotech
VitroScan provides ex vivo micro-tumor testing platforms and predictive assays designed to forecast patient responses to cancer treatments. The company serves clinicians and biopharmaceutical developers by enabling personalized therapy selection, improving clinical trial stratification, and de-risking oncology drug development.
Health
Allcyte was an Austrian life-sciences technology company that developed AI-enabled live-cell imaging and single-cell analysis for functional precision medicine. Its platform analyzed patient-derived tumor samples to support oncology drug discovery and treatment-response research for pharmaceutical, biotechnology, and clinical research users.
Biotechnology
Deep Cell Industries Inc. provides an AI-integrated platform called REM-I that combines label-free imaging, deep learning, and cell enrichment for single-cell morpholomic analysis. The company serves researchers and organizations in oncology, drug discovery, cell and gene therapy, and related life science fields by enabling high-resolution profiling and sorting of viable cells.
Biotech, Diagnostics
Novigenix is an immuno-transcriptomics and TechBio company that provides precision oncology solutions for biopharmaceutical companies and researchers. It offers LITOseek, an AI-powered liquid biopsy platform that analyzes gene activity in immune cells to support biomarker discovery, therapy development, and patient response monitoring.
Biotechnology & Pharmaceuticals
Cancer Research Horizons is a specialist drug discovery, development, and commercialisation company that translates lab-bench innovations into diagnostics and treatments for cancer patients. The company collaborates with researchers, partners, and investors to advance oncology therapeutics, manage start-ups, and license research tools and data portfolios.
Similar health care company
DoMore Diagnostics develops artificial intelligence technology for digital pathology and cancer diagnostics, aiming to personalize cancer treatment, improve patient care, and support drug development. The company offers products such as Histotype Px® Colorectal to provide precise cancer prognosis and reduce over- and undertreatment for patients.
Healthcare
CureMetrix is a San Diego-based medical artificial intelligence company that develops FDA-cleared software designed to assist radiologists with mammography analysis and breast health diagnostics.
Similar health care company
IDL Diagnostics (formerly AroCell) develops and provides medical diagnostic products focusing on oncology and bacteriology. The company offers specialized tests and assays, such as tumor markers and rapid diagnostic solutions, to healthcare providers and researchers.
Healthcare
Proteomedix is a Swiss diagnostics company and spin-out of ETH Zurich dedicated to developing innovative diagnostic solutions, such as prostate cancer tests.
Similar health care company
Prostatype Genomics develops, manufactures, and markets Prostatype, a prognostic genetic test for prostate cancer. The test combines gene expression data with clinical parameters to assess cancer aggressiveness and help doctors and patients determine appropriate treatment decisions.
Healthcare
Innocras is a genomic analysis and cancer big data company founded in South Korea by physician-scientists from KAIST, maintaining research and corporate presence in both the United States and Korea. The company specializes in advanced cancer diagnostics and genomic technology to support precision oncology.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of 2cureX and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for 2cureXand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →